Drug
Alfalfa, Allium Sativum, Asparagus Officinalis, Avena Sativa, Belladonna, Berberis Vulgaris, Chelidonium Majus, Glycyrrhiza Glabra, Hydrastis Canadensis, Juniperus Virginiana, Niccolum Metallicum, Passiflora Incarnata, Sarcolacticum Acidum, Solidago Virgaurea, Taraxacum Officinale
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Impaired Work Ability | 17 | 10.9 | 11.0 | signal |
| 2 | Tendonitis | 12 | 10.6 | 10.7 | signal |
| 3 | Product Substitution Issue | 43 | 10.3 | 10.5 | signal |
| 4 | Quality Of Life Decreased | 10 | 10.2 | 10.3 | signal |
| 5 | Muscle Tightness | 11 | 9.3 | 9.4 | signal |
| 6 | Activities Of Daily Living Impaired | 11 | 7.5 | 7.6 | signal |
| 7 | Bedridden | 7 | 7.3 | 7.4 | signal |
| 8 | Spinal Disorder | 5 | 7.2 | 7.3 | signal |
| 9 | Muscle Twitching | 12 | 7.1 | 7.2 | signal |
| 10 | Thinking Abnormal | 9 | 6.6 | 6.6 | signal |
| 11 | Hypoaesthesia Oral | 7 | 6.4 | 6.4 | signal |
| 12 | Local Swelling | 8 | 6.2 | 6.2 | signal |
| 13 | Scab | 5 | 6.1 | 6.1 | signal |
| 14 | Impaired Driving Ability | 5 | 6.0 | 6.1 | signal |
| 15 | Musculoskeletal Pain | 23 | 6.0 | 6.1 | signal |
| 16 | Movement Disorder | 14 | 6.0 | 6.0 | signal |
| 17 | Photosensitivity Reaction | 7 | 5.8 | 5.9 | signal |
| 18 | Blood Iron Decreased | 5 | 5.8 | 5.8 | signal |
| 19 | Emotional Disorder | 13 | 5.8 | 5.8 | signal |
| 20 | Paralysis | 6 | 5.7 | 5.8 | signal |
| 21 | Therapy Change | 4 | 5.7 | 5.7 | signal |
| 22 | Tendon Rupture | 5 | 5.6 | 5.6 | signal |
| 23 | Bladder Disorder | 4 | 5.5 | 5.5 | signal |
| 24 | Abasia | 10 | 5.5 | 5.5 | signal |
| 25 | Dry Throat | 4 | 5.4 | 5.4 | signal |
| 26 | Economic Problem | 6 | 5.4 | 5.4 | signal |
| 27 | Poor Venous Access | 4 | 5.3 | 5.3 | signal |
| 28 | Body Height Decreased | 4 | 5.1 | 5.1 | signal |
| 29 | Gastrointestinal Pain | 4 | 5.0 | 5.0 | signal |
| 30 | Pruritus Generalised | 8 | 5.0 | 5.0 | signal |
| 31 | Tooth Fracture | 4 | 5.0 | 5.0 | signal |
| 32 | Ageusia | 9 | 4.9 | 5.0 | signal |
| 33 | Coordination Abnormal | 5 | 4.9 | 4.9 | signal |
| 34 | Rebound Effect | 4 | 4.8 | 4.9 | signal |
| 35 | Accident | 4 | 4.6 | 4.6 | signal |
| 36 | Therapy Cessation | 17 | 4.6 | 4.6 | signal |
| 37 | Blood Glucose Abnormal | 6 | 4.5 | 4.5 | signal |
| 38 | Ovarian Cancer | 3 | 4.5 | 4.5 | signal |
| 39 | Nightmare | 11 | 4.3 | 4.4 | signal |
| 40 | Inability To Afford Medication | 3 | 4.2 | 4.2 | signal |
| 41 | Injection Site Warmth | 6 | 4.0 | 4.0 | signal |
| 42 | Euphoric Mood | 3 | 4.0 | 4.0 | signal |
| 43 | Scratch | 3 | 4.0 | 4.0 | signal |
| 44 | Product Odour Abnormal | 3 | 4.0 | 4.0 | signal |
| 45 | Injection Site Urticaria | 7 | 4.0 | 4.0 | signal |
| 46 | Abnormal Dreams | 8 | 4.0 | 4.0 | signal |
| 47 | Anosmia | 4 | 3.8 | 3.8 | signal |
| 48 | Pulmonary Thrombosis | 3 | 3.8 | 3.8 | no signal |
| 49 | Anger | 9 | 3.6 | 3.7 | signal |
| 50 | Pain Of Skin | 7 | 3.6 | 3.6 | signal |
| 51 | Ankylosing Spondylitis | 3 | 3.2 | 3.2 | no signal |
| 52 | Drug Effect Decreased | 12 | 3.0 | 3.0 | signal |
| 53 | Wrong Technique In Drug Usage Process | 8 | 3.0 | 3.0 | signal |
| 54 | Central Nervous System Lesion | 3 | 3.0 | 3.0 | no signal |
| 55 | Injection Site Bruising | 17 | 3.0 | 3.0 | signal |
| 56 | Menorrhagia | 4 | 2.8 | 2.8 | no signal |
| 57 | Injection Site Erythema | 24 | 2.7 | 2.7 | signal |
| 58 | Tooth Loss | 4 | 2.6 | 2.6 | no signal |
| 59 | Drug Dose Omission | 31 | 2.5 | 2.6 | signal |
| 60 | Injection Site Swelling | 14 | 2.5 | 2.6 | signal |
| 61 | Injection Site Pruritus | 12 | 2.5 | 2.5 | signal |
| 62 | Application Site Pruritus | 4 | 2.4 | 2.4 | no signal |
| 63 | Injection Site Pain | 51 | 2.3 | 2.4 | signal |
| 64 | Injection Site Reaction | 10 | 2.0 | 2.0 | signal |
| 65 | Intentional Drug Misuse | 3 | 1.9 | 1.9 | no signal |
| 66 | Incorrect Route Of Drug Administration | 5 | 1.9 | 1.9 | no signal |
| 67 | Skin Irritation | 6 | 1.8 | 1.8 | no signal |
| 68 | Injection Site Haemorrhage | 10 | 1.7 | 1.7 | no signal |
| 69 | Device Malfunction | 8 | 1.6 | 1.6 | no signal |
| 70 | Application Site Erythema | 3 | 1.6 | 1.6 | no signal |
| 71 | Drug Withdrawal Syndrome | 10 | 1.5 | 1.6 | no signal |
| 72 | Tardive Dyskinesia | 3 | 1.4 | 1.4 | no signal |